Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Blinatumomab
Related studies linked through entity extraction aliases.
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- NA
Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL
- Status
- RECRUITING
- Phase
- NA
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
- Status
- RECRUITING
- Phase
- NA
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
ALL Backbone in AYAs
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1